RG13022 50 mg | 98.38%
TargetMol
RG13022 (Tyrphostin RG13022) is a tyrosine kinase inhibitor; inhibits the autophosphorylation reaction of the EGF receptor (IC50: 4 μM).
More Information Supplier PageRG13022
Search Results
RG13022 25 mg | 98.38%
TargetMol
RG13022 (Tyrphostin RG13022) is a tyrosine kinase inhibitor; inhibits the autophosphorylation reaction of the EGF receptor (IC50: 4 μM).
More Information Supplier PageRG13022
RG13022 10 mg | 98.38%
TargetMol
RG13022 (Tyrphostin RG13022) is a tyrosine kinase inhibitor; inhibits the autophosphorylation reaction of the EGF receptor (IC50: 4 μM).
More Information Supplier PageRG13022
Sotagliflozin 50 mg | 98.00%
TargetMol
LX-4211 is an orally bioavailable inhibitor of the sodium-glucose co-transporter subtype 1 (SGLT1) and 2 (SGLT2), with potential antihyperglycemic activity.
More Information Supplier PageSotagliflozin
Sotagliflozin 5 mg | 98.00%
TargetMol
LX-4211 is an orally bioavailable inhibitor of the sodium-glucose co-transporter subtype 1 (SGLT1) and 2 (SGLT2), with potential antihyperglycemic activity.
More Information Supplier PageSotagliflozin
JK184 10 mg | 99.37%
TargetMol
JK184
JK184 100 mg | 99.37%
TargetMol
JK184
TMS 5 mg | 99.42%
TargetMol
TMS is a very selective and potent competitive inhibitor of P450 1B1 (CYP1A1).
More Information Supplier PageTMS
TMS 50 mg | 99.42%
TargetMol
TMS is a very selective and potent competitive inhibitor of P450 1B1 (CYP1A1).
More Information Supplier PageTMS
TMS 25 mg | 99.42%
TargetMol
TMS is a very selective and potent competitive inhibitor of P450 1B1 (CYP1A1).
More Information Supplier PageTMS